The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Efficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator
Open accessAbstract
BACKGROUND: The extravascular implantable cardioverter-defibrillator (ICD) has a single lead implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and defibrillation energy similar to that of transvenous ICDs. The safety and efficacy of extravascular ICDs are not yet known. METHODS: We conducted a prospective, single-group, nonrandomized, premarket global clinical study involving patients with a class I or IIa indication for an ICD, all of whom received an extravascular ICD system. The primary efficacy end point was successful defibrillation at implantation. The efficacy objective would be met if the lower boundary of the one-sided 97.5% confidence interval for the percentage of patients with successful defibrillation was greater than 88%. The primary safety end point was freedom from major system- or procedure-related complications at 6 months. The safety objective would be met if the lower boundary of the one-sided 97.5% confidence interval for the percentage of patients free from such complications was greater than 79%. RESULTS: A total of 356 patients were enrolled, 316 of whom had an implantation attempt. Among the 302 patients in whom ventricular arrhythmia could be induced and who completed the defibrillation testing protocol, the percentage of patients with successful defibrillation was 98.7% (lower boundary of the one-sided 97.5% confidence interval [CI], 96.6%; P<0.001 for the comparison with the performance goal of 88%); 299 of 316 patients (94.6%) were discharged with a working ICD system. The Kaplan-Meier estimate of the percentage of patients free from major system- or procedure-related complications at 6 months was 92.6% (lower boundary of the one-sided 97.5% CI, 89.0%; P<0.001 for the comparison with the performance goal of 79%). No major intraprocedural complications were reported. At 6 months, 25 major complications were observed, in 23 of 316 patients (7.3%). The success rate of antitachycardia pacing, as assessed with generalized estimating equations, was 50.8% (95% CI, 23.3 to 77.8). A total of 29 patients received 118 inappropriate shocks for 81 arrhythmic episodes. Eight systems were explanted without extravascular ICD replacement over the 10.6-month mean follow-up period. CONCLUSIONS: In this prospective global study, we found that extravascular ICDs were implanted safely and were able to detect and terminate induced ventricular arrhythmias at the time of implantation. (Funded by Medtronic; ClinicalTrials.gov number, NCT04060680.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Linde, C., Abraham, W. T., Gold, M. R., St. John Sutton, M., Ghio, S., & Daubert, C. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.027 · Cited by 1,261
Biventricular Pacing for Atrioventricular Block and Systolic Dysfunction
Curtis, A. B., Worley, S. J., Adamson, P. B., Chung, E. S., Niazi, I., Sherfesee, L., Shinn, T., & St. John Sutton, M. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1210356 · Cited by 854
An Entirely Subcutaneous Implantable Cardioverter–Defibrillator
Bardy, G. H., Smith, W. M., Hood, M. A., Crozier, I. G., Melton, I. C., Jordaens, L., Theuns, D., Park, R. E., Wright, D. J., Connelly, D. T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909545 · Cited by 780
Self-citationSafety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator
Weiss, R., Knight, B. P., Gold, M. R., Leon, A. R., Herre, J. M., Hood, M., Rashtian, M., Kremers, M., Crozier, I., Lee, K. L., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003042 · Cited by 557
Self-citationSafety and Efficacy of the Totally Subcutaneous Implantable Defibrillator
Burke, M. C., Gold, M. R., Knight, B. P., Barr, C. S., Theuns, D. A. M. J., Boersma, L. V. A., Knops, R. E., Weiss, R., Leon, A. R., Herre, J. M., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.047 · Cited by 505
Self-citationSubcutaneous or Transvenous Defibrillator Therapy
Knops, R. E., Olde Nordkamp, L. R. A., Delnoy, P.-P. H. M., Boersma, L. V. A., Kuschyk, J., El-Chami, M. F., Bonnemeier, H., Behr, E. R., Brouwer, T. F., Kääb, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915932 · Cited by 483
Self-citationImplant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry
Boersma, L., Barr, C., Knops, R., Theuns, D., Eckardt, L., Neuzil, P., Scholten, M., Hood, M., Kuschyk, J., Jones, P., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.06.040 · Cited by 331
Self-citationComplications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients
ALTER, P., WALDHANS, S., PLACHTA, E., MOOSDORF, R., & GRIMM, W. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.00195.x · Cited by 274
Healey, J. S., Hohnloser, S. H., Glikson, M., Neuzner, J., Mabo, P., Vinolas, X., Kautzner, J., O'Hara, G., VanErven, L., Gadler, F., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61903-6 · Cited by 245
Self-citation
Cited by
Marijon, E., Narayanan, K., Smith, K., Barra, S., Basso, C., Blom, M. T., Crotti, L., D'Avila, A., Deo, R., Dumas, F., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00875-9 · Cited by 313
Lampert, R., Chung, E. H., Ackerman, M. J., Arroyo, A. R., Darden, D., Deo, R., Dolan, J., Etheridge, S. P., Gray, B. R., Harmon, K. G., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.05.018 · Cited by 167
Metadata
- Authors
- Friedman, P., Murgatroyd, F., Boersma, L. V. A., Manlucu, J., O’Donnell, D., Knight, B. P., Clémenty, N., Leclercq, C., Amin, A., Merkely, B. P., Birgersdotter-Green, U. M., Chan, J. Y. S., Biffi, M., Knops, R. E., Engel, G., Muñoz Carvajal, I., Epstein, L. M., Sagi, V., Johansen, J. B., Sterliński, M., Steinwender, C., Hounshell, T., Abben, R., Thompson, A. E., Wiggenhorn, C., Willey, S., & Crozier, I.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2022-10-06
- Volume
- 387
- Issue
- 14
- Pages
- 1292-1302
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4293514805
- Cited by
- 255
- References
- 29
- FWCI
- 29.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator. https://app.cochat.ai/papers/10.1056/nejmoa2206485
- The paper
- Friedman, P., Murgatroyd, F., Boersma, L. V. A., Manlucu, J., O’Donnell, D., Knight, B. P., Clémenty, N., Leclercq, C., Amin, A., Merkely, B. P., Birgersdotter-Green, U. M., Chan, J. Y. S., Biffi, M., Knops, R. E., Engel, G., Muñoz Carvajal, I., Epstein, L. M., Sagi, V., Johansen, J. B., . . . Crozier, I. (2022). Efficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2206485
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.